Arteris, Inc. (NASDAQ:AIP – Get Free Report) COO Laurent Moll sold 1,552 shares of the firm’s stock in a transaction dated Monday, April 6th. The stock was sold at an average price of $18.23, for a total value of $28,292.96. Following the transaction, the chief operating officer owned 280,972 shares of the company’s stock, valued at $5,122,119.56. This trade represents a 0.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Arteris Price Performance
Shares of AIP opened at $18.24 on Tuesday. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $19.85. The company has a market capitalization of $829.37 million, a price-to-earnings ratio of -22.24 and a beta of 1.43. The business has a 50-day moving average of $15.67 and a 200-day moving average of $14.96.
Arteris (NASDAQ:AIP – Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $20.14 million for the quarter, compared to the consensus estimate of $18.55 million. As a group, sell-side analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current year.
Key Arteris News
- Neutral Sentiment: CEO K. Charles Janac sold 9,009 shares at an average $17.65 for $159,009; post-sale ownership ~208,529 shares (−4.14%). The sale was executed under a pre-arranged 10b5-1 plan to cover tax withholding. SEC Filing
- Neutral Sentiment: COO Laurent R. Moll sold 1,552 shares at an average $18.23 for $28,293; post-sale ownership ~280,972 shares (−0.55%). The sale was part of a pre-arranged 10b5-1 plan to cover tax obligations. SEC Filing
- Neutral Sentiment: COO Laurent R. Moll also sold 5,602 shares at $17.65 for $98,875; post-sale ownership ~282,524 shares (−1.94%). Executed under a 10b5-1 plan for tax withholding on vested awards. SEC Filing
- Neutral Sentiment: CFO Nicholas B. Hawkins sold 4,870 shares at $17.65 for $85,956; post-sale ownership ~118,614 shares (−3.94%). Sale made to cover tax withholding and disclosed via SEC filing. SEC Filing
- Neutral Sentiment: VP Paul L. Alpern sold 3,649 shares at $17.65 for $64,405; post-sale ownership ~86,386 shares (−4.05%). Also executed to cover tax withholding on vested awards. SEC Filing
- Neutral Sentiment: CEO K. Charles Janac additionally sold 11,800 shares at $18.34 for $216,412; post-sale ownership ~196,729 shares (−5.66%). Executed under a pre-arranged 10b5-1 plan to cover tax withholding. SEC Filing
Institutional Investors Weigh In On Arteris
Large investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. acquired a new stake in Arteris during the second quarter worth approximately $32,000. BNP Paribas Financial Markets grew its stake in Arteris by 75.0% in the third quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after acquiring an additional 2,595 shares during the period. New York State Common Retirement Fund grew its stake in Arteris by 352.4% in the fourth quarter. New York State Common Retirement Fund now owns 9,500 shares of the company’s stock valued at $147,000 after acquiring an additional 7,400 shares during the period. Mercer Global Advisors Inc. ADV acquired a new stake in Arteris in the fourth quarter valued at approximately $162,000. Finally, Penn Capital Management Company LLC acquired a new stake in Arteris in the third quarter valued at approximately $109,000. Institutional investors and hedge funds own 64.36% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts recently commented on AIP shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research note on Wednesday, January 21st. Wall Street Zen raised Arteris from a “hold” rating to a “buy” rating in a research note on Saturday, March 21st. Northland Securities set a $24.00 target price on Arteris in a research note on Friday, February 13th. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $20.00 target price on shares of Arteris in a research note on Friday, February 13th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $20.17.
View Our Latest Analysis on Arteris
Arteris Company Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Further Reading
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
